These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 9376997

  • 1. Relationship between urinary excretion of modified nucleosides and rheumatoid arthritis process.
    Tebib JG, Reynaud C, Cedoz JP, Letroublon MC, Niveleau A.
    Br J Rheumatol; 1997 Sep; 36(9):990-5. PubMed ID: 9376997
    [Abstract] [Full Text] [Related]

  • 2. Urinary modified nucleosides as tumor markers in cancer of the urinary organs or female genital tract.
    Koshida K, Harmenberg J, Stendahl U, Wahren B, Borgström E, Helström L, Andersson L.
    Urol Res; 1985 Sep; 13(5):213-8. PubMed ID: 4060364
    [Abstract] [Full Text] [Related]

  • 3. Breast cancer prognostic significance of some modified urinary nucleosides.
    Sasco AJ, Rey F, Reynaud C, Bobin JY, Clavel M, Niveleau A.
    Cancer Lett; 1996 Nov 29; 108(2):157-62. PubMed ID: 8973589
    [Abstract] [Full Text] [Related]

  • 4. Monitoring of urinary excretion of modified nucleosides in cancer patients using a set of six monoclonal antibodies.
    Reynaud C, Bruno C, Boullanger P, Grange J, Barbesti S, Niveleau A.
    Cancer Lett; 1992 Jan 31; 61(3):255-62. PubMed ID: 1739950
    [Abstract] [Full Text] [Related]

  • 5. The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancer.
    Waalkes TP, Gehrke CW, Zumwalt RW, Chang SY, Lakings DB, Tormey DC, Ahmann DL, Moertel CG.
    Cancer; 1975 Aug 31; 36(2):390-8. PubMed ID: 1157009
    [Abstract] [Full Text] [Related]

  • 6. Quantitation of urinary nucleosides by high-performance liquid chromatography.
    Liebich HM, Di Stefano C, Wixforth A, Schmid HR.
    J Chromatogr A; 1997 Feb 28; 763(1-2):193-7. PubMed ID: 9129323
    [Abstract] [Full Text] [Related]

  • 7. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers.
    Langridge JI, McClure TD, el-Shakawi S, Fielding A, Schram KH, Newton RP.
    Rapid Commun Mass Spectrom; 1993 Jun 28; 7(6):427-34. PubMed ID: 8329765
    [Abstract] [Full Text] [Related]

  • 8. High-performance liquid chromatographic separation and quantitation of nucleosides in urine and some other biological fluids.
    Davis GE, Suits RD, Kuo KC, Gehrke CW, Waalkes TP, Borek E.
    Clin Chem; 1977 Aug 28; 23(8):1427-35. PubMed ID: 872405
    [No Abstract] [Full Text] [Related]

  • 9. Urinary excretion of modified nucleosides in chronic myelogenous leukemia.
    Heldman DA, Grever MR, Speicher CE, Trewyn RW.
    J Lab Clin Med; 1983 May 28; 101(5):783-92. PubMed ID: 6572681
    [Abstract] [Full Text] [Related]

  • 10. Nucleoside excretion in breast cancer: comparison with other biochemical tumour-index-substances.
    Coombes RC, Powles TJ, Gehrke CW, Waalkes TP, Neville AM.
    Invest Cell Pathol; 1979 May 28; 2(1):11-4. PubMed ID: 511604
    [Abstract] [Full Text] [Related]

  • 11. Possible use of urinary modified RNA metabolites in the measurement of RNA turnover in the human body.
    Sander G, Topp H, Wieland J, Heller-Schöch G, Schöch G.
    Hum Nutr Clin Nutr; 1986 Mar 28; 40(2):103-18. PubMed ID: 2420752
    [Abstract] [Full Text] [Related]

  • 12. Differential excretion of modified nucleosides in adult acute leukemia.
    Heldman DA, Grever MR, Trewyn RW.
    Blood; 1983 Feb 28; 61(2):291-6. PubMed ID: 6571786
    [Abstract] [Full Text] [Related]

  • 13. A quantitative approach to determining disease response during therapy using multiple biologic markers: application to carcinoma of the breast.
    Woo KB, Waalkes TP, Ahmann DL, Tormey DC, Gehrke CW, Oliverio VT.
    Cancer; 1978 May 28; 41(5):1685-703. PubMed ID: 348295
    [Abstract] [Full Text] [Related]

  • 14. The urinary excretion of the nucleosides pseudouridine and 1-methylinosine during normal menstrual cycle.
    Lehtiö H, Mäenpää PH.
    Clin Chim Acta; 1977 Oct 01; 80(1):181-5. PubMed ID: 908140
    [Abstract] [Full Text] [Related]

  • 15. [Excretion of methylated nucleosides in the initial therapy phase in a case of anorexia nervosa].
    Clemens P, Schöch G, Ziemer G, Altenhoff J, Erb N, Lorenz H, Müller J, Grüttner R.
    Padiatr Padol; 1982 Oct 01; 17(2):157-63. PubMed ID: 7099674
    [Abstract] [Full Text] [Related]

  • 16. Relationship of urinary excretion of modified nucleosides to disease status in childhood acute lymphoblastic leukemia.
    Heldman DA, Grever MR, Miser JS, Trewyn RW.
    J Natl Cancer Inst; 1983 Aug 01; 71(2):269-73. PubMed ID: 6576186
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Quantitative determination of methylated nucleosides and pseudouridine in urine by gas-liquid chromatography.
    Chang SY, Lakings DB, Zumwalt RW, Gehrke CW, Waalkes TP.
    J Lab Clin Med; 1974 May 01; 83(5):816-30. PubMed ID: 4821860
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.